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Functional near-infrared spectroscopy (fNIRS) is a relatively new technique that can mea-
sure hemoglobin changes in brain tissues, and its use in psychiatry has been progressing
rapidly. Although it has several disadvantages (e.g., relatively low spatial resolution and the
possibility of shallow coverage in the depth of brain regions) compared with other functional
neuroimaging techniques (e.g., functional magnetic resonance imaging and positron emis-
sion tomography), fNIRS may be a candidate instrument for clinical use in psychiatry, as
it can measure brain activity in naturalistic position easily and non-invasively. fNIRS instru-
ments are also small and work silently, and can be moved almost everywhere including
schools and care units. Previous fNIRS studies have shown that patients with schizophre-
nia have impaired activity and characteristic waveform patterns in the prefrontal cortex
during the letter version of the verbal fluency task, and part of these results have been
approved as one of the Advanced MedicalTechnologies as an aid for the differential diagno-
sis of depressive symptoms by the Ministry of Health, Labor and Welfare of Japan in 2009,
which was the first such approval in the field of psychiatry. Moreover, previous studies sug-
gest that the activity in the frontopolar prefrontal cortex is associated with their functions in
chronic schizophrenia and is its next candidate biomarker. Future studies aimed at exploring
fNIRS differences in various clinical stages, longitudinal changes, drug effects, and varia-
tions during different task paradigms will be needed to develop more accurate biomarkers
that can be used to aid differential diagnosis, the comprehension of the present condition,
the prediction of outcome, and the decision regarding treatment options in schizophrenia.
Future fNIRS researches will require standardized measurement procedures, probe set-
tings, analytical methods and tools, manuscript description, and database systems in an
fNIRS community.
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INTRODUCTION
Techniques that allow the easier and less invasive measurement of
brain structure and activity, such as magnetic resonance imaging
(MRI), functional MRI,and positron emission tomography (PET),
have progressed rapidly over the past 20 years. There has been
considerable expectation regarding the clinical application of neu-
roimaging techniques to psychological conditions and psychiatric
illnesses (1, 2). Biological markers measured using neuroimaging
instruments would clarify the pathophysiological features of psy-
chiatric disorders, inform patients and family members regarding
their actual conditions, and improve general impression of psy-
chiatric disorders, by more easily giving the explanation of their
conditions and discussing their assumed prognoses.
Functional near-infrared spectroscopy (fNIRS) is a functional
brain imaging tool that can measure hemoglobin changes over the
surface of the brain easily and non-invasively (Figure 1) (3–5).
fNIRS technique was found in 1977 (6), and has been applied to
measure brain hemodynamic activity through the scalp (7, 8). The
release of commercial fNIRS machines that are small, movable, and
work silently during the last decade (Figure 1B) has allowed the
progress of fNIRS research in the field of psychiatry (9). In 2012,
more than 100 studies were published on this subject; among these,
about 20 articles pertained to the field of psychiatry (9). Part of
the results of those fNIRS studies has been approved as one of the
Advanced Medical Technologies as an aid for the differential diag-
nosis of depressive symptoms by the Ministry of Health, Labor and
Welfare of Japan in 2009 (10–12), as the presence of different char-
acteristic waveform patterns in the prefrontal cortex (PFC) during
a verbal fluency task (VFT) has been reported among patients with
major depressive illness (4, 12–17), bipolar disorder (12, 13), and
schizophrenia (4, 5, 12). This was the first such approval in the
field of psychiatry in Japan (see the “Application to supplemen-
tary diagnostic tool for psychiatric disorders” subsection). Here,
we reviewed fNIRS research that focused on schizophrenia, which
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FIGURE 1 |Theoretical background and measurement settings of
fNIRS. (A) Illustration of a simple source and detector probe set. When
near-infrared light is emitted from a source probe onto the human scalp, it
passes and scatters through brain tissues with relatively low absorption.
Subsequently, part of this light is absorbed by blood hemoglobin in small
vessels. A detector probe, normally placed 3 cm away from the source
probe in adults, can detect scattered near-infrared light reflected by the
surface of the cortex. (B) fNIRS measurement setting (ETG-4000, Hitachi
Medical Corporation). Commercial fNIRS machines are small, movable, and
work silently, so that they are easy to use in clinical settings. (C,D) 3×11
Probe attachment and fitting condition. Multi-channel fNIRS machines use
multiple sources and detector probes and are able to measure brain activity
between the probes. (A–C) Was approved by Hitachi Medical Corporation.
is currently the most published topic in the application of fNIRS
in the field of psychiatry, and address future investigations that are
needed for the clinical application of this technique as an aid for
the differential diagnosis, comprehension of present conditions,
prediction of outcome, and decision regarding treatment options
in schizophrenia.
PRINCIPLES OF BRAIN ACTIVITY MEASUREMENT USING
NEAR-INFRARED LIGHT
THEORETICAL BACKGROUND OF THE MEASUREMENT OF BRAIN
ACTIVITY USING fNIRS INSTRUMENTS
Near-infrared light, especially that with a wavelength of 650–
1000 nm, has characteristics that include a relatively high absorp-
tion through hemoglobin, as well as a relatively high penetration
through bone and skin, compared with light with other wave-
lengths. The emission of near-infrared light from a source probe on
the human scalp leads to its passing and scattering through brain
tissues with relatively low absorption, followed by the absorption
of part of this light by blood hemoglobin in small vessels (<1 mm)
(18). A detector probe, which is normally placed 3 cm away from
the source probe in adults, can detect scattered near-infrared light
that is reflected by the surface of the cortex (Figure 1A). Therefore,
the region located between the source and the detector probes is
generally set as a measurement area that is often called a “chan-
nel” (Figure 1C). fNIRS instruments can measure oxygenated
hemoglobin (O2Hb) and deoxygenated hemoglobin (HHb), as
well as total hemoglobin (tHb) by summing up O2Hb and HHb,
by using near-infrared light with two or more different wave-
lengths that are slightly different from the absorption rates of
O2Hb and HHb. In accordance with light manipulation, fNIRS
instruments are roughly divided into three types: continuous wave
(CW), frequency domain (FD), and time domain (TD) instru-
ments. Although CW-type fNIRS machines are unable to measure
absolute hemoglobin concentration in tissues, they are relatively
small, have low installation and maintenance costs, and are able
to perform measurements at a high sampling rate compared with
FD- and TD-type fNIRS machines (18). Therefore, recent clinical
studies have used CW-type fNIRS machines (19, 20). The the-
oretical details of all types of fNIRS instruments were reviewed
elsewhere (18, 20, 21).
ADVANTAGES AND DISADVANTAGES OF fNIRS COMPARED WITH
OTHER FUNCTIONAL IMAGING INSTRUMENTS
The advantages and disadvantages of CW-type fNIRS compared
with other functional imaging instruments (fMRI, PET, and EEG)
are shown in Table 1. fNIRS has the following advantages: (1)
non-invasiveness, which allows repetitive measurements, even in
infants (21, 22); (2) easy setting; (3) small size and portability; (4)
high temporal resolution compared with fMRI and PET (18, 20);
(5) possibility of performing measurements in a non-restrained
position, such that participants can sit on a chair, talk, and move
their hands; and (6) possibility of relatively easily combining mea-
surements with other neuroimaging techniques, such as EEG (23,
24), MRI (25–30), PET (31–33), and magnetoencephalography
(MEG) (34, 35). Conversely, fNIRS has the following disadvan-
tages: (1) low spatial resolution (10–30 mm); (2) possibility of
performing measurements only at the surface of the cortex; (3)
inability to measure absolute hemoglobin value (CW-type); and
(4) the data obtained can be influenced by scalp, muscle, skull, and
cerebrospinal fluid factors in addition to hemodynamic changes
in the cortex (20).
Other than task-related hemoglobin changes derived from
neural activities under neurovascular coupling, fNIRS signals vary
depending on task-related blood pressure changes and skin blood
flow, as well as spontaneous brain activity related to heart rate,
respiration, and physiological oscillations (20, 21). Simultane-
ous measurements by fNIRS and pulse Doppler sonography or
by fNIRS with different probe distances [e.g., shallow (5 mm)
and deep (30 mm)] allow the distinction of fNIRS signals from
the cortex from those of other brain tissues. A study based on
fNIRS with different probe distances and laser Doppler velocime-
try showed that hemoglobin changes from the cortex during the
VFT may contain only 6% of fNIRS data in the PFC, and that
most signal changes may arise from changes in skin blood flow
(36). The results OPF simultaneous fNIRS, fMRI, MR angiogra-
phy, and peripheral physiological measurements suggested that
task-evoked sympathetic arterial vasoconstriction affected fNIRS
signal changes substantially (37). However, a subsequent study in
which simultaneous measurements using multiple fNIRS probe
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Table 1 | Comparison of CW-type fNIRS machines with other neuroimaging tools.
fNIRS fMRI PET EEG MEG
Theoretical
background
Signal property Scattered
near-infrared light
Magnetic
property
Uptake of ligand
marked positron
Collection of neural
activity
Magnetic fields produced
by brain’s electrical activity
Measurement area Surface of the
cortex
Whole brain
region
Whole brain
region
Surface of the cortex
unless using depth EEG
Surface of the cortex
Time resolution (s) 1 2–3 ≥10 0.01 0.01
Spatial resolution
(mm)
20 5 10 20 10
Effect of
extra-cortical tissue
Some Little Little Some None
Measurement
setting
Invasiveness No No Intravenous
injection of
radioactive ligand
No No
Body movement Tolerable No No No No
Head restraint No Yes Yes No Yes
Instrument Size Small, movable Large, fix Large, fix Large in research use Large, fix
Transportability Yes No No Limited No
Initial cost 300,000–400,000
USDa
Several million
USD
Several million
USD
100,000–300,000 USD Several million USD
Measurement and
maintenance cost
Reasonable Moderate Very expensive
(positron ligand)
Reasonable Moderate
Bold shows advantages compared to other neuroimaging tools.
aETG-4000 (Hitachi Medical Corporation).
distances and laser Doppler flowmetry were performed suggested
that about 50% of fNIRS signals contributed to the fNIRS sig-
nal component in the deep layer, mostly measured in the cortex,
during several cognitive tasks, including the VFT (38). A study of
simultaneous measurement using fMRI, fNIRS, and lase Doppler
flowmeter showed that the prefrontal fNIRS signals were signif-
icantly correlated with the blood oxygenation level-dependent
(BOLD) signals in the gray matter rather than those in the soft
tissue or the laser Doppler signals (39). Previous studies have sug-
gested that the ratio of fNIRS signal changes in the cortex varies
from 6 to 60%, and the variation has been considered as being
caused by differences in measuring instruments, estimation meth-
ods, and brain areas measured (20, 36–38, 40–44). Several studies
have provided filtering methods that allow raising the ratio of
task-related hemoglobin changes in the cortex to in the extra-
cortical tissues; however, these systems require additional probes
and complex analytical methodologies because of different near-
infrared absorption and scattering coefficients in each tissue and
anatomic characteristics throughout the light path in each brain
area (25, 38, 40, 41). Therefore, fNIRS is a reliable tool for research
based on the group-level and/or channel-cluster-level investiga-
tions, although its reliability at the individual and single-channel
levels is not sufficient (18, 45–48). Few studies in clinical psy-
chiatry have considered these filtering methods because of the
limitations of measurement time and setting. Future studies will
be needed to improve the signal-to-noise ratio for application over
wide measurement areas without losing the advantage of fNIRS
instruments.
COMPARISON OF fNIRS HEMOGLOBIN CHANGES WITH BOLD SIGNALS
IN fMRI
The measurement of brain activity using the fMRI technique
has progressed during the last two decades. The BOLD signal
is thought to represent the differences in the magnetic prop-
erties of deoxygenated hemoglobin concentration under T2-
weighted measurement conditions when cerebral blood flow
(CBF) increases and HHb decreases in small vessels (49). The
theoretical model of BOLD compared with fNIRS signals was
reviewed in detail elsewhere (18). Briefly, localized O2Hb decreases
and HHb increases occur (i.e., initial dip) when neurons are acti-
vated in a specific region. Several seconds later, the blood flow
system is triggered to request glucose to the region (i.e., hemo-
dynamic response), which is followed by a CBF increase and
peripheral vascular bed dilation, leading to tHb increase and HHb
decrease in small vessels, and O2Hb increase in blood capillaries
and vascular bed. As this neurovascular coupling that occurs in
the activated area is thought to vary according to brain area and
vessel diameter, and to be sensitive to persistent neural activity,
the relationship between hemoglobin changes and BOLD/fNIRS
signals has a complex variation pattern.
Other than the difference in spatio-temporal measurement
characteristics between BOLD and fNIRS signals, the BOLD sig-
nal is thought to detect mainly changes in the magnetic properties
of small vessels, whereas the fNIRS signal is thought to detect
changes in near-infrared light absorption in blood capillaries (50).
Therefore, several discrepancies may occur between BOLD and
fNIRS signals. Previous fNIRS studies have yielded inconsistent
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results compared with other imaging tools. Simultaneous fNIRS
and fMRI studies have shown that the BOLD signal in a specific
region was associated with the O2Hb of fNIRS signal changes in
the corresponding region (25, 29, 39, 51) or with HHb changes
(26–28, 30, 51). One of the explanations for these inconsistent
correlation results is that most fNIRS studies have been conducted
using block-designed tasks, whereas fMRI studies have mainly
used an event-related design. In addition, the analysis of fMRI
data by software such as Statistical Parametric Mapping (SPM)
uses a hypothesis that fits a probable activation model, whereas
most fNIRS studies have analyzed average signal intensity dur-
ing the whole task period without any probable activation model.
Differences in acquired signal handling may result in discrepan-
cies regarding regions with significant brain activity. As O2Hb
data generally exhibit larger changes compared with HHb during
cognitive activity, most clinical fNIRS studies have mainly been
analyzed using O2Hb data.
ESTIMATION OF BRAIN AREA
As more studies have focused on the spatial characteristics of brain
activity using multi-channel fNIRS instruments, the need to clar-
ify the estimated location of each probe in the cortex and each
channel on the scalp has arisen. As reviewed by Tsuzuki et al.
recently (52), several methodologies can estimate brain areas at
each probe and channel, such as structural MRI measurement
using fNIRS probe marks for each participant (53, 54), a prob-
abilistic registration method using a 3D digitizer (55), and a
probabilistic virtual registration method without any additional
instrument (56). As the virtual registration method enables the
estimation of brain areas based on standard brain images at
each probe and channel by defining only probe setting based on
the 10–20 system electrode locations, and because this method
has similar accuracy compared with other estimation method-
ologies (56), most fNIRS studies have applied this method to
estimate the measurement brain areas of channels. fNIRS soft-
ware can also use the virtual registration method as a toolbox
(http://www.jichi.ac.jp/brainlab/tools.html) (57). There are sev-
eral standard stereotaxic coordinate systems such as the Montreal
Neurological Institute (MNI) and the Talairach Daemon. The
LONI Probabilistic Brain Atlas (LPBA40) (58) system has been
often used in fNIRS studies based on probabilistic registration
methods (3, 52, 59, 60).
APPLICATION OF fNIRS IN SCHIZOPHRENIA RESEARCH
Schizophrenia is a syndrome that is characterized by positive
and negative symptoms and cognitive dysfunction with enduring
social deficits. Moreover, it affects approximately 0.7% of the gen-
eral population (2). The World Health Organization reported that
the estimated burden of schizophrenia accounts for 2.3% of all dis-
eases worldwide, and its disability-adjusted life year ranks ninth
among all non-communicable diseases (61). However, effective
treatments and objective indices for all symptoms and functions
of schizophrenia have not been fully met.
Since the first fNIRS report of altered activation patterns in
schizophrenia compared with healthy controls was published in
1994 (62), fNIRS research focusing on schizophrenia has been the
most published topic in the field of psychiatry (9). We reviewed
systematically research articles published up to April 1, 2013, by
searching PubMed and Web of Science. As in previous systematic
reviews (9, 18), we used “[(near infrared) OR (optical topogra-
phy)] AND (schizo* OR psycho*) AND (brain OR cortex)” as a
search term. Two hundred and sixty articles were extracted, among
which 29 explored brain activity in patients with schizophrenia.
Half of these articles (15 articles, including 4 studies of genetic
variants) adopted a VFT as an activation cognitive battery during
measurement.
VERBAL FLUENCY TASK
The VFT is a popular cognitive task that is used in neuropsycho-
logical tests and neuroimaging measurements to explore various
cognitive functions during verbal recall, retrieval, working mem-
ory, attention, and inhibition (avoiding inappropriate words) (63,
64). During the task, participants are instructed to say as many
words from a given paradigm as possible in a given time (usually
60 s). This paradigm is roughly divided into semantic (category
fluency task, CFT), such as fruits, or phonological (letter fluency
task, LFT), such as words that begin with the letter “p.” Neuropsy-
chological studies have revealed that patients with schizophrenia
have worse VFT performances compared with healthy controls
(65). Although fMRI and fNIRS studies have shown that rela-
tively global brain activity occurs during the VFT compared with
a task that requires specific cognitive domains, such as the n-back
working-memory task (28, 66) and the go/no-go task (67), most
participants (including patients with chronic schizophrenia) can
perform the task (10, 11, 19, 63, 64).
Eleven previous VFT studies are listed in Table 2. Watanabe and
Kato firstly described that patients with schizophrenia had reduced
O2Hb and HHb changes in the left PFC during the LFT compared
with healthy controls (68). This study also demonstrated that
patients who were medicated with atypical antipsychotics had bet-
ter task performances and similar O2Hb changes compared with
controls, suggesting that typical antipsychotics may impair task
response and brain activity. However, that study did not explore
whether impaired O2Hb changes were derived from impaired task
response or functional impairment in the PFC, which may be ame-
liorated by atypical antipsychotics. Suto et al. firstly described the
spatio-temporal activity patterns in the PFC and temporal cortex
among patients with depression and schizophrenia and healthy
controls using two 24-channel fNIRS machines (4). In that study,
a modified task procedure was adopted in which three initial syl-
lables changed in turn every 20 s during a 60 s task period, to
help participants avoid silence and reduce differences in task per-
formances among groups. Patients with schizophrenia had lower
activity in the bilateral PFC and temporal cortex at the start of the
task period compared with controls, whereas patients with depres-
sion had lower activity in the bilateral PFC and temporal cortex
across the task period. These results were irrespective of task per-
formance, and the task paradigm used in that study was used
widely in further studies. In addition, this result was based on the
Advanced Medical Technologies in Japan (10–12). Using a larger
cohort, Takizawa et al. replicated the observation that patients with
schizophrenia had slower and inappropriate activity after the task
period compared with healthy controls (5). Furthermore, activities
in the frontopolar prefrontal cortex (FPC) region were positively
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Table 2 | Previous fNIRS studies in schizophrenia using verbal fluency tasks.
Reference Place fNIRS instrument Case demographics
Modela Number of
analyzed
channels
Number of
cases (M/F)
Mean age in
cases (SD)
Medication Recruitment
places
Shimodera et al. (73) Kochi OMM-3000/16 42 32 (12/19) 42.4 (15.7) All University hospital
Koike et al. (3) Tokyo ETG-4000 52 38 (22/16)b 31.3 (6.1)b Allb University hospital,
psychiatric hospital, health
service center, and clinics
Takeshi et al. (72) Tokyo (Toho
University)
OMM-3000/16 24 18 (7/11) 25.4 (5.8) All NA
Azechi et al. (70) Osaka OMM-3000/16 2 30 (16/14)c 39.6 (13.1)c All University hospital
Quaresima et al. (69) L’Aquila NIRO-300 2 9 (5/4) 32.1 (8.3) All NA
Ikezawa et al. (71) Osaka NIRO-200 2 30 (12/18) 38.7 (11.7) Two patients
drug naïved
University hospital
Takizawa et al. (5) Tokyo ETG-4000 52 55 (26/29) 40.1 (11.1) All University hospital
Ehlis et al. (74) Wuerzburg ETG-100 22 12 (9/3) 34.2 (10.4) One patient
drug naïve
NA
Kubota et al. (75) Cleveland NIRO-300 2 16 (8/8) 37.5 (13.0) All NA
Suto et al. (4) Gunma ETG-100 48 13 (9/4) 37.9 (12.0) All University hospital
Watanabe and Kato (68) Ehime HEO-200 1 62 (30/32) 40.1 (12.3) All Psychiatric hospital
Reference Task setting Resultse
Pre-task
condition
Task condition Post-task
condition
Patients
compared
to controls
Estimated regions
for group
differences
Multiple
analysis
correlation
Shimodera et al. (73) 30-s Rest 30-s×2 Letter sets 70-s Rest ↓ Bilateral FPC, DLPFC,
and VLPFC regions
Bonferroni
Koike et al. (3) 60-s Vowel
repeats
20-s×3 Letter sets 70-s Vowel repeats ↓f Bilateral FPC, DLPFC,
and VLPFC regionsf
FDR
Takeshi et al. (72) 60-s Vowel
repeats
20-s×3 Letter sets 70-s Vowel repeats ↓ Bilateral dorsal FPC and
DLPFC
No
Azechi et al. (70) 30-s Vowel
repeats
20-s×3
Letter/category sets
60-s Vowel repeats ↓g Bilateral FPC No
Quaresima et al. (69) 120-s Rest 30-s×4 Letter sets No setting ↓ Bilateral FPC No
Ikezawa et al. (71) 30-s Vowel
repeats
20-s×3
Letter/category sets
60-s Vowel repeats ↓g Bilateral FPC ANCOVA
Takizawa et al. (5) 60-s Vowel
repeats
20-s×3 Letter sets 70-s Vowel repeats ↓ Bilateral FPC, DLPFC,
and VLPFC regions
FDR
Ehlis et al. (74) 10-s Rest 30-s Letter/category
and 30-s rest×2
sets
30-s Control task
(repeatedly say weekdays)
and 30-s rest between the
sets of task conditions
↓g Left DLPFC and VLPFC ANOVA
(Continued)
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Table 2 | Continued
Reference Task setting Resultse
Pre-task
condition
Task condition Post-task
condition
Patients
compared
to controls
Estimated regions
for group
differences
Multiple
analysis
correlation
Kubota et al. (75) 20-s A vowel
repeats
15-s×6
Letter/category sets
No setting ↓g Bilateral FPC ANOVA
Suto et al. (4) 30-s Vowel
repeats
20-s×3 Letter sets 60-s Vowel repeats – – ANOVA
Watanabe and Kato
(68)
15-s No detailed
description
60-s One letter set 15-s No detailed
description
↓ Left FPC ANOVA
Reference Correlational analysis between clinical variables and fNIRS signals
GAF Other clinical variables Medication
Shimodera et al. (73) NA n.s. NA
Koike et al. (3) Positive association in the
FPC region in the chronic
schizophrenia group
Positive association with PANSS positive or negative scores in
the FEP group
n.s. (including no
difference between
UHR individuals with
and without medication)
Takeshi et al. (72) n.s., But positive
association in the FPC
during an idea fluency task
NA NA
Azechi et al. (70) NA n.s. n.s.
Quaresima et al. (69) NA NA NA
Ikezawa et al. (71) NA n.s. n.s.
Takizawa et al. (5) Positive association in the
FPC and right DLPFC
regions
Negative correlation with age at measurement, positive
correlation with PANSS positive score, and negative correlation
with PANSS general psychopathology score in schizophrenia
n.s.
Ehlis et al. (74) NA NA n.s.
Kubota et al. (75) NA NA NA
Suto et al. (4) NA NA NA
Watanabe and Kato (68) NA n.s. n.s.
Excluded previous gene association studies.
NA, not applicable; n.s., no significant correlation; FPC, the frontopolar prefrontal cortex; DLPFC, dorsolateral prefrontal cortex; VLPFC, ventrolateral prefrontal cortex;
FDR, false discovery rate; GAF, the global assessment of functioning; PANSS, the positive and negative symptom scale; FEP, first-episode psychosis, UHR, ultra-high
risk.
aOMM-3000/16, Shimadzu Corporation; ETG-4000 and ETG-100, Hitachi Medical Corporation; NIRO-300 and NIRO-200, Hamamatsu Photonics Corporation; HEO-200,
Omron Healthcare Corporation.
bExhibit case in the chronic schizophrenia group. Sixteen UHR and 2 FEP individuals were antipsychotics naïve and 8 UHR and 1 FEP individuals were drug naïve.
cAs Azechi et al. (70) used the same sample from Ikezawa et al. (71) as the First group, we describe for the Second group.
dBy Azechi et al. (70).
eResults from brain activity during the whole of the task period.
fResults in the chronic schizophrenia group.
gResults during the letter fluency tasks.
associated with global assessment of functioning scores in schizo-
phrenia. Quaresuma et al. replicated the finding of reduced brain
activity in schizophrenia during the LFT, whereas no significant
change was observed during a visual spatial working memory task
(69). Ikezawa et al. and Azechi et al. showed the efficacy of the
LFT task in fNIRS (70, 71). Ikezawa et al. measured hemoglobin
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changes in the PFC using a two-channel fNIRS instrument dur-
ing the LFT, CFT, Tower of Hanoi (TOH), the Sternberg task,
and the Stroop task, and showed that brain activities during the
LFT and TOH were significantly different between patients with
schizophrenia and healthy controls (71). Azechi et al. explored
this further using discrimination analysis and showed that 88.3%
of participants correctly discriminated between patients and con-
trols based on task performance on the TOH, LFT, and CFT, and
on fNIRS signals during the VFT (70). This result confirmed that
75% of independent participants were able to discriminate cor-
rectly using the same procedure. Koike et al. explored the signal
differences among different clinical stages of schizophrenia (ultra-
high risk, first-episode psychosis, and chronic schizophrenia) and
showed that the activities in the FPC, ventrolateral PFC (VLPFC),
and temporal cortex were lower in patients than they were in
controls, whereas the activities in the dorsolateral PFC (DLPFC)
decreased with advancing clinical stage (3). Those authors also
replicated the finding that the activity in the FPC region was pos-
itively associated with global assessment of functioning scores
in chronic schizophrenia, implying that it may be a candidate
biomarker for the assessment of psychological condition in schiz-
ophrenia (3, 5). Takeshi et al. measured brain activity during the
idea fluency task, which is thought to require more executive func-
tion, and showed that patients with schizophrenia had decreased
activity in the ventral area of the PFC (72). Furthermore, these
signal changes were positively associated with the global assess-
ment of functioning scores, whereas O2Hb changes during the
LFT were not. Shimodera et al. replicated the characteristic wave-
forms in schizophrenia, such as smaller initial activity at the start
of the task period, reduced activity during the task period, and
inappropriate activity after the task period, and used a numerical
calculation (73).
The CFT has also been used in fNIRS studies, which often com-
pare this task to the LFT. Kubota et al. used a two-channel fNIRS
instrument to show for the first time that healthy controls had
larger activity in the PFC during the LFT than in the CFT under
similar task performances, whereas patients with schizophrenia
had smaller activity during the LFT than during the CFT (75).
Patients with schizophrenia had smaller activity than did healthy
controls under similar task performances between the groups. This
result is consistent with those of other studies (70, 71). Ehlis et al.
used a multi-channel fNIRS instrument that covered the left fron-
totemporal region and found that healthy controls had larger and
spatially wider activities during the LFT compared with the CFT
(74), which was then replicated by measuring wider areas of the
bilateral prefrontal/temporal cortices (76). Ehlis et al. also repli-
cated the finding that patients with schizophrenia had significantly
reduced activities compared with healthy controls during LFT, but
not during the CFT.
APPLICATION OF fNIRS AS A SUPPLEMENTARY DIAGNOSIS TOOL FOR
PSYCHIATRIC DISORDERS
As described above, previous studies using a block-design LFT
have indicated that patients with schizophrenia have not only
reduced activity, but also inappropriate activity timing, espe-
cially at the start of the task period and post-task period, com-
pared with healthy controls (4, 5). Subsequently, the Joint Project
for Psychiatric Application of Near-Infrared Spectroscopy (JPSY-
NIRS) Group has applied to these results and improved in the
applicable way for clinical settings. The integral value (the size of
the fNIRS signal area during the task period) and centroid value
(the centroid time of the fNIRS signal area throughout the task)
were determined by using averaged brain signals estimated in the
frontopolar cortex. This group showed preliminarily that 69% of
patients with MDD and 69% of patients with schizophrenia, and
69% MDD patients and 81% BP patients were correctly differ-
entiated under an algorithm using these two values (10, 11). A
part of these results was approved as one of the Advanced Medical
Technologies as an aid for the differential diagnosis of depressive
symptoms in 2009, which was the first such approval in the field of
psychiatry in Japan (10, 11). Several criticisms have arisen regard-
ing the limited replication in various clinical settings and the lack
of consensus for application to mental health (77, 78). However,
paper published recently on JPSY-NIRS replicated previous results
(12). Using this algorithm, fNIRS can differentiate patients with
depressive symptoms between major depressive disorder and psy-
chotic disorders (bipolar disorder and schizophrenia), with a high
classification rate (74.6 and 85.5%, respectively).
OTHER COGNITIVE TASKS AND MEASUREMENT SETTINGS
Three studies have explored the differences in brain activity during
a random generation task (RNG) between patients with schizo-
phrenia and healthy controls. Sinba et al. used a two-channel fNIRS
instrument to describe for the first time that patients with schizo-
phrenia had reduced brain activity in the PFC and worse task per-
formances during the RNG compared with healthy controls, which
represented different features during ruler-catching and sequential
finger-to-thumb tasks (79). As healthy controls with better RNG
task performances had greater brain activity, it remained unclear
whether low brain activity was derived from worse task execution
and/or functional impairment in schizophrenia. Hoshi et al. used
time-resolved spectroscopy and two-channel fNIRS instruments
to show that patients with schizophrenia, particularly those with a
longer duration of illness, had reduced hemoglobin concentration
during the resting state, and that this may cause altered activity
during the RNG task (80). Koike et al. used a multi-channel fNIRS
instrument to show that patients with schizophrenia had signifi-
cantly reduced activity in the bilateral DLPFC and VLPFC regions,
and that the activity in the right DLPFC region was associated with
an earlier age at onset (81).
Okada et al. firstly showed the presence of altered brain activ-
ity in schizophrenia using a two-channel fNIRS instrument (62).
Patients with schizophrenia had an aberrant task-related response
pattern during a mirror drawing task, which was thought to be
derived from a disrupted interhemispheric integration. Fallgatter
et al. also showed the presence of altered frontal lateralization in
schizophrenia during a continuous performance task using a two-
channel fNIRS instrument (82). Folley et al. explored brain activ-
ity in patients with schizophrenia, individuals with schizotypal
personality, and healthy controls during a divergent-thinking task
using a two-channel fNIRS instrument, and showed that individu-
als with schizotypal personality had enhanced divergent-thinking
ability and greater brain activity in the right PFC compared with
patients with schizophrenia and healthy controls (83). Lee et al.
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showed alternations in brain activity using fMRI and 24-channel
fNIRS (not simultaneously) during the same event-related spatial
working-memory task: patients with schizophrenia recruited the
bilateral PFC, whereas healthy controls recruited only the right
PFC (28). Zhu et al. used a 48-channel fNIRS instrument to show
that patients with first-episode schizophrenia had reduced brain
activity over the PFC during the Tower of London task (84).
Nishimura et al. used a 52-channel fNIRS instrument during a
go-no-go task to show that healthy controls had a significant
decrease in activity in the DLPFC during the no-go condition,
whereas patients with schizophrenia exhibited no changes (67).
Furthermore, the high excitement score observed in patients with
schizophrenia was associated with brain activity in the FPC and
right DLPFC. Taniguchi et al. used a 24-channel fNIRS instrument
to show that patients with schizophrenia had reduced brain activity
in the PFC compared with healthy controls during a kana Stroop
task, with similar task performances, whereas both patients and
controls showed lack of activity during a kanji Stroop task, with
significantly worse performance observed in the schizophrenia
group (85).
Other than cognitive tasks, Fujita et al. explored hemoglobin
changes through an electroconvulsive therapy using a two-channel
fNIRS instrument, and showed that patients with schizophrenia
had asymmetric hemoglobin changes in the PFC compared with
patients with depression (86).
GENETIC VARIATION
Although schizophrenia is a syndrome, has been considered as a
consolidation of several pathophysiological features, and has high
genetic heritability, no crucial genetic risk factor has been found
(87, 88). The results of genome-wide association studies that used
a large sample size have suggested that schizophrenia risk genes are
unable to be determined by specific gene variants but are thought
to consist of common variants; furthermore, these risk genes had
a substantial influence on environmental effects that occurred
before the onset of schizophrenia. To clarify the impact of spe-
cific genes related to schizophrenia on the brain, imaging/genetics
studies were performed to explore the relationship between brain
structure and activity and genetic variants.
Five studies have explored the relationship between genetic
variants and brain activity using fNIRS instruments. Takizawa
et al. firstly reported that the val108/158met polymorphism of
the catechol-O-methyltransferase (COMT ) gene affected brain
activity in the PFC only in schizophrenia patients (and not in
healthy controls) (89). Schizophrenia patients with the Met variant
(Val/Met and Met/Met) had significantly greater activation in the
bilateral FPC and DLPFC during the LFT than did Val/Val carriers,
implying that the inverted U curve shift of dopamine availability in
schizophrenia might have an effect on the brain activity in the PFC
(89). Regarding the Gln/Pro polymorphism of the sigma-1 recep-
tor gene, Takizawa et al. reported that patients with the Gln/Gln
genotype had significantly greater brain activity in the FPC and
left DLPFC during the LFT than did Pro allele carriers; however,
no significant differences were observed in healthy controls (90).
However, Ohi et al. later used a two-channel fNIRS machine and a
larger sample set to show that this genotype effect occurred in both
the schizophrenia and control groups (91). Ohi et al. also reported
that individuals with a longer cytosine/adenine/guanine (CAG)
repeat in the spinocerebellar ataxia type 17 gene had reduced
activity in the bilateral PFC during the TOH task in both the
schizophrenia and control groups (92). Regarding the rs41279104
polymorphism of the nitric oxide synthase-I gene, Reif et al.
showed that patients who were A allele carriers had significantly
reduced activity in the right PFC during a VFT compared with
those who had the GG genotype (93).
As recent methodological progress in gene analysis allows the
exploration of whole genetic alterations between cases and con-
trols using more than 10,000 samples, imaging/genetics studies
should be performed using methods that enable the analysis of
numerical data sets, such as bioinformatics and machine learning
methods (94). Conversely, the investigation of the relationship
between brain activity and relevant target genes (e.g., DLPFC
function under dopamine regulation and COMT variants) may
provide another imaging/genetics study strategy. The analysis of
altered gene function in the brain among psychiatric illnesses may
clarify the pathophysiology of specific psychiatric disorders and
identify new treatment options.
EFFECT OF MEDICATION ON BRAIN ACTIVITY
As previous clinical fNIRS studies have mostly explored patients in
the chronic stage and receiving medication, the effect of medica-
tion on brain function was a limitation of these studies. Although
an inconsistent effect of medication on fNIRS signal has been
reported (68, 70, 71, 79), most previous fNIRS studies have
reported an absence of association between brain activity and
medication dose (3, 5, 12, 74, 81, 84–86) or different brain activity
between individuals with ultra-high risk for psychosis with and
without medication (3) (Table 1). However, all of those studies
were cross-sectional, and a previous randomized and controlled
trial showed that the administration of mirtazapine increased
brain activity compared with trazodone and placebo in healthy
volunteers (95). Controlled trials and/or longitudinal investigation
to elucidate specific drug effects will be needed.
LIMITATIONS OF PREVIOUS STUDIES AND FURTHER
DIRECTIONS
The previous fNIRS studies of schizophrenia had several limita-
tions; therefore, we propose further directions for future investi-
gation (Table 3). First, as most previous studies have performed
cross-sectional measurements in chronic and stable patients
receiving medication, symptomatic, and functional changes were
not fully explored. As fNIRS is able to perform measurements
relatively easily in unstable patients, such as those with acute or
recurrent conditions, longitudinal studies aimed at investigating
changes in clinical symptoms and social function will be needed (3,
96). Although previous studies have revealed a negligible medica-
tion effect on fNIRS signals, investigations of drug-naïve patients
or of those receiving controlling treatment (e.g., specific drugs,
electroconvulsive therapy, and neurofeedback) will be needed to
allow further clinical applications of fNIRS (60, 86, 97). The use of
the easy portability of fNIRS machines may allow measurements
in earlier clinical stages in cohort settings, such as adolescents
with psychotic-like experiences, which may reveal the alterations
in brain development in the PFC (98).
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Table 3 | Limitation of previous fNIRS studies and further implication.
Limitation of previous studies Further implications
Cross-sectional measurement for
chronic and stable patients with
medication
Measure in different clinical stages (e.g., UHR, FEP, recurrent phase)
Measure longitudinally to explore the relationship between clinical changes and fNIRS signals
Measure in drug-naïve patients to explore drug effect
Measure in a specific treatment response (e.g., medication, electroconvulsive therapy, neurofeedback)
Measure in cohort setting (e.g., psychotic-like experiences)
One-sided task procedure
(block-designed VFTs)
Use of other cognitive tasks
Adopt event-related design
Adopt more naturalistic task (e.g., driving, conversation)
Small sample size in single institute Make consortium with the same instrument and measurement procedure (e.g., task paradigm, probe setting)
Adopt more sophisticated analytical methods (e.g., measurement tools, bioinformatics, machine learning)
Standardize manuscript description
Construct fNIRS community
UHR, ultra-high risk; FEP, first-episode psychosis.
Second, half of the previous studies of schizophrenia adopted
block-design VFTs for cognitive activation. Although one of the
major disadvantages of fNIRS is the inability to measure brain
activity in deep brain tissues, and the block-design VFT is appro-
priate for elucidating brain activity over the PFC, other cognitive
tasks, and event-related design will be helpful to explore brain
pathology in schizophrenia and to compare signal differences
between fNIRS and other neuroimaging tools, such as fMRI and
PET. Conversely, the exploration of brain activity in a more nat-
uralistic position and during natural activities, such as driving
and conversation, is suitable for future investigations using the
advantages of fNIRS (99, 100).
Third, as fNIRS allows easy and repetitive measurements, a
study including a large number of samples has been conducted
(12). To analyze such a large data set, the same measurement
procedure regarding task paradigm and probe setting and more
sophisticated analytical methods, such as measurement tools (e.g.,
NIRS-SPM) (101), bioinformatics methods, and machine learn-
ing (94), will be needed. Standardized manuscript description and
a database system will be needed for further comparisons and
meta-analyses (102). The construction of an fNIRS community is
expected to provide this type of background in NIRS research (18).
CONCLUSION
Functional near-infrared spectroscopy has been progressing
rapidly in the field of psychiatry, as it provides several advantages,
such as small size, portability, silent functioning, and the achieve-
ment of easy and non-invasive measurements. A part of these
results was approved in 2009 as one of the Advanced Medical
Technologies as an aid for the differential diagnosis of depres-
sive symptoms (10–12), which was the first such approval in
the field of psychiatry in Japan. Future investigations aimed at
exploring fNIRS differences in various clinical stages, longitu-
dinal changes, drug effects, and variations during different task
paradigms will be needed to develop more accurate biomark-
ers that can be used to aid differential diagnosis, the compre-
hension of the present condition, the prediction of outcome,
and the decision regarding treatment options in schizophrenia.
Future fNIRS research environments will require standardized
measurement procedures, probe settings, analytical methods and
tools, manuscript description, and database systems in a n fNIRS
community.
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